BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33011289)

  • 1. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
    Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
    Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
    Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
    Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.
    Zhou J; Han J; Nutescu EA; Patel PR; Sweiss K; Calip GS
    Pharmacotherapy; 2019 Jan; 39(1):55-66. PubMed ID: 30485471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
    Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.
    Sorror ML; Logan BR; Zhu X; Rizzo JD; Cooke KR; McCarthy PL; Ho VT; Horowitz MM; Pasquini MC
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1479-87. PubMed ID: 25862591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.
    Ohbiki M; Ito Y; Inamoto Y; Miyamura K; Uchida N; Fukuda T; Fujiwara H; Nishida T; Hayashi M; Tanaka M; Kawakita T; Ikegame K; Katayama Y; Ara T; Ichinohe T; Kiyoi H; Matsuo K; Atsuta Y
    Transplant Cell Ther; 2023 Dec; 29(12):768.e1-768.e10. PubMed ID: 37739224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure.
    Kundu R; Seeger R; Elfassy MD; Rozenberg D; Ahluwalia N; Detsky ME; Ferreyro BL; Mehta S; Law AD; Minden M; Prica A; Sklar M; Munshi L
    Ann Hematol; 2023 Feb; 102(2):439-445. PubMed ID: 36542101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
    Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
    J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Friend BD; Broglie L; Logan BR; Chhabra S; Bupp C; Schiller G; Beitinjaneh A; Perez MAD; Guilcher GMT; Hashem H; Hildebrandt GC; Krem MM; Lazarus HM; Nishihori T; Nusrat R; Rotz SJ; Wirk B; Wieduwilt M; Pasquini M; Savani BN; Stadtmauer EA; Sorror ML; Thakar MS
    Transplant Cell Ther; 2023 Feb; 29(2):123.e1-123.e10. PubMed ID: 36442769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Economic Burden Associated with Transplantation-Related Complications.
    Perales MA; Bonafede M; Cai Q; Garfin PM; McMorrow D; Josephson NC; Richhariya A
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1788-1794. PubMed ID: 28688917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in Children.
    Forlanini F; Zinter MS; Dvorak CC; Bailey-Olson M; Winestone LE; Shimano KA; Higham CS; Melton A; Chu J; Kharbanda S
    Transplant Cell Ther; 2022 Mar; 28(3):155.e1-155.e8. PubMed ID: 34848362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Passweg JR; Labopin M; Christopeit M; Cornelissen J; Pabst T; Socié G; Russel N; Yakoub-Agha I; Blaise D; Gedde-Dahl T; Labussière-Wallet H; Malladi R; Forcade E; Maury S; Polge E; Lanza F; Gorin NC; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):659-664. PubMed ID: 31759159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe sepsis in hematopoietic stem cell transplant recipients*.
    Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
    Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study.
    Archanjo LVF; Caruso P; Nassar Junior AP
    Sao Paulo Med J; 2022; 141(2):107-113. PubMed ID: 35920534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
    Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
    Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiologies and Outcome of Patients with Solid Tumors Admitted to ICU with Acute Respiratory Failure: A Secondary Analysis of the EFRAIM Study.
    Benguerfi S; Dumas G; Soares M; Meert AP; Martin-Loeches I; Pene F; Bauer P; Mehta S; Metaxa V; Burghi G; Kouatchet A; Montini L; Mokart D; Van de Louw A; Azoulay E; Lemiale V;
    Respir Care; 2023 Jun; 68(6):740-748. PubMed ID: 37072164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.